Hyperglycemia causes oxidative stress in pancreatic β-cells of GK rats, a model of type 2 diabetes

Diabetes

Volumn 48, Issue 4, 1999, Pages 927-932

  Ihara, Yu ^a   Toyokuni, Shinya ^a   Uchida, Koji ^b   Odaka, Hiroyuki ^c   Tanaka, Tomoyuki ^a   Ikeda, Hitoshi ^c   Hiai, Hiroshi ^a   Seino, Yutaka ^a   Yamada, Yuichiro ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; 8 HYDROXYDEOXYGUANOSINE; GLUCOSE; INSULIN; REACTIVE OXYGEN METABOLITE; SUCROSE; VOGLIBOSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL LEVEL; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT;

EID: 0032998220     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.4.927     Document Type: Article

References (39)

1. Halliwell B, Gutteridge JMC: Free Radicals in Biology and Medicine. 2nd ed. Oxford, Clarendon, 1989
2. Brownlee M, Vlassara H, Cerami A: Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 101:527-537, 1984
3. Sakurai T, Tsuchiya S: Superoxide production from nonenzymatically glycated protein. FEBS Lett 236:406-410, 1988
4. Njoroge FG, Monnier VM: The chemistry of the Maillard reaction under physiological conditions: a review. Prog Clin Biol Res 304:85-107, 1989
5. Lenzen S, Drinkgern J, Tiedge M: Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med 20:463-466, 1996
6. Tiedge M, Lortz S, Drinkgern J, Lenzen S: Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 46:1733-1742, 1997
7. Kwon G, Corbett JA, Rodi CP, Sullivan P, McDaniel ML: Interleukin-1 beta-induced nitric oxide synthase expression by rat pancreatic beta-cells: evidence for the involvement of nuclear factor kappa B in the signaling mechanism. Endocrinology 136:4790-4795, 1995
8. Eizirik DL, Flodstrom M, Karlsen AE, Welsh N: The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic beta cells. Diabetologia 39:875-890, 1996
9. Mandrup PT: The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39:1005-1029, 1996
10. Rabinovitch A, Suarez PW: Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 55:1139-1149, 1998
11. Kasai H, Nishimura S: Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res 12:2137-2145, 1984
12. Kasai H: Analysis of a form of oxidative DNA damage. 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 387:147-163, 1997
13. Toyokuni S: Reactive oxygen species-induced molecular damage and its application in pathology. Pathol Int 49:91-102, 1999
14. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, Nicotera T: Oxidative damage to DNA in diabetes mellitus. Lancet 347:444-445, 1996
15. Leinonen J, Lehtimaki T, Toyokuni S, Okada K, Tanaka T, Hiai H, Ochi H, Laippala P, Rantalaiho V, Wirta O, Pasternack A. Alho H: New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett 417:150-152, 1997
16. Goto Y, Suzuki K, Sasaki MM, Abe S: GK rats as a model of nonobese, non-insulin-dependent diabetes: selective breeding over 35 generations. In Frontiers in Diabetes Research: Lessons from Animal Diabetes II. Shafrir E, Renold AE, Eds. London, John Libbey, 1988, p. 301-303
17. Goto Y, Suzuki K, Ono T, Sasaki M, Toyota T: Development of diabetes in the non-obese NIDDM rat (GK rat). Adv Exp Med Biol 246:29-31, 1988
18. Portha B, Serradas P, Bailbe D, Suzuki K, Goto Y, Giroix MH: β-Cell insensitivity to glucose in the GK rat: a spontaneous nonobese model for type II diabetes. Diabetes 40:486-491, 1991
19. Bisbis S, Bailbe D, Tormo MA, Picarel BF, Derouet M, Simon J, Portha B: Insulin resistance in the GK rat: decreased receptor number but normal kinase activity in liver. Am J Physiol 265:E807-E813, 1993
20. + channels is impaired in β-cells of the GK rat: a new genetic model of NIDDM. Diabetes 42:1446-1453, 1993
21. 2+ channel activities in pancreatic beta cells of non-insulin-dependent diabetes mellitus GK rats. J Clin Invest 97:2417-2425, 1996
22. Toyokuni S, Tanaka T, Hattori Y, Nishiyama Y, Yoshida A, Uchida K, Hiai H, Ochi H, Osawa T: Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest. 76:365-374, 1997
23. Esterbauer H, Schaur RJ, Zollner H: Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11:81-128, 1991
24. Uchida K, Szweda LI, Chae HZ, Stadtman ER: Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proc Natl Acad Sci USA 30:8742-8746, 1993
25. Uchida K, Toyokuni S, Nishikawa K, Kawakishi S, Oda H, Hiai H. Stadtman ER: Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis. Biochemistry 33:12487-12494, 1994
26. Toyokuni S, Uchida K, Okamoto K, Hattori NY Hiai H, Stadtman ER: Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc Natl Acad Sci USA 91:2616-2620, 1994
27. Toyokuni S, Luo XP, Tanaka T, Uchida K, Hiai H, Lehotay DC: Induction of a wide range of C(2-12) aldehydes and C(7-12) acyloins in the kidney of Wistar rats after treatment with a renal carcinogen, ferric nitrilotriacetate. Free Radic Biol Med 22:1019-1027, 1997
28. Tanaka T, Nishiyama Y, Okada K, Hirota K, Matsui M, Yodoi J, Hiai H, Toyokuni S: Induction and nuclear translocation of thioredoxin by oxidative damage in the mouse kidney: independence of tubular necrosis and sulfhydryl depletion. Lab Invest 77:145-155, 1997
29. Goto Y, Yamada K, Ohyama T, Matsuo T, Odaka H, Ikeda H: An alpha-glucosidase inhibitor, AO-128, retards carbohydrate absorption in rats and humans. Diabetes Res Clin Pract 28:81-87, 1995
30. Matsumoto K, Yano M, Miyake S, Ueki Y, Yamaguchi Y, Akazawa S, Tominaga Y: Effects of voglibose on glycemic excursions, insulin secretion, and insulin sensitivity in non-insulin-treated NIDDM patients. Diabetes Care 21:256-260, 1998
31. Hsu SM, Raine L, Fanger H: A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 75:734-738, 1981
32. Michel C, Chariot J, Souchard M, Roze C: Modifications of the endocrine pancreas in rats after ethionine destruction of acini. Cell Mol Biol 28:135-148, 1982
33. Movassat J, Saulnier C, Portha B: Beta-cell mass depletion precedes the onset of hyperglycaemia in the GK rat, a genetic model of non-insulin-dependent diabetes mellitus. Diabetes Metab 21:365-370, 1995
34. Movassat J, Saulnier C, Serradas P, Portha B: Impaired development of pancreatic beta-cell mass is a primary event during the progression to diabetes in the GK rat. Diabetologia 40:916-925, 1997
35. Poll G, Parola M: Oxidative damage and fibrogenesis. Free Radic Biol Med 22:287-305, 1997
36. Gepts W: The pancreas and diabetes. In Systemic Pathology. Vol. 12, The Endocrine System, 3rd ed. Lewis PD, Ed. Edinburgh, U.K., Churchill Livingstone, 1996, p. 221-254
37. Yki-Jarvinen H: Glucose toxicity. Endocr Rev 13:415-431, 1992
38. Kubisch HM, Wang J, Bray TM, Phillips JP: Targeted overexpression of Cu/Zn superoxide dismutase protects pancreatic β-cells against oxidative stress. Diabetes 46:1563-1566, 1997
39. Hohmeier HE, Thigpen A, Tran VV, Davis R, Newgard CB: Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1beta-induced cytotoxicity and reduces nitric oxide production. J Clin Invest 101:1811-1820, 1998